blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1055665

EP1055665 - 3-(3-Hydroxyphenyl)-3-amino-propionamide derivatives [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.08.2004
Database last updated on 02.09.2024
Most recent event   Tooltip27.08.2004No opposition filed within time limitpublished on 13.10.2004  [2004/42]
Applicant(s)For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, CT 06340 / US
[N/P]
Former [2003/43]For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, Connecticut 06340 / US
Former [2000/48]For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, Connecticut 06340 / US
Inventor(s)01 / Liras, Spiros
Pfizer Central Research, Eastern Point Road
Groton, Connecticut 06340 / US
[2000/48]
Representative(s)Simpson, Alison Elizabeth Fraser, et al
Urquhart-Dykes & Lord LLP The Podium
1 Eversholt Street
London NW1 2DN / GB
[N/P]
Former [2000/48]Simpson, Alison Elizabeth Fraser, et al
Urquhart-Dykes & Lord, 30 Welbeck Street
London W1M 7PG / GB
Application number, filing date00304372.624.05.2000
[2000/48]
Priority number, dateUS19990136548P28.05.1999         Original published format: US 136548 P
[2000/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1055665
Date:29.11.2000
Language:EN
[2000/48]
Type: B1 Patent specification 
No.:EP1055665
Date:22.10.2003
Language:EN
[2003/43]
Search report(s)(Supplementary) European search report - dispatched on:EP23.08.2000
ClassificationIPC:C07C237/20, C07C237/24, C07D277/30, A61K31/165, A61P29/00
[2000/48]
CPC:
A61K31/165 (EP); A61P1/00 (EP); A61P1/04 (EP);
A61P11/06 (EP); A61P13/00 (EP); A61P17/02 (EP);
A61P19/02 (EP); A61P25/00 (EP); A61P25/04 (EP);
A61P29/00 (EP); A61P37/02 (EP); C07C237/20 (EP);
C07C237/24 (EP); C07D277/28 (EP); C07C2601/02 (EP);
C07C2601/14 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/48]
TitleGerman:3-(3-Hydroxyphenyl)-3-amino-propionamidderivate[2000/48]
English:3-(3-Hydroxyphenyl)-3-amino-propionamide derivatives[2000/48]
French:Dérivés de la 3-(3-hydroxyphényl)-3-amino-propionamide[2000/48]
Examination procedure02.06.2000Examination requested  [2000/48]
07.03.2002Despatch of a communication from the examining division (Time limit: M06)
24.10.2002Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
23.12.2002Reply to a communication from the examining division
10.04.2003Communication of intention to grant the patent
11.08.2003Fee for grant paid
11.08.2003Fee for publishing/printing paid
Opposition(s)23.07.2004No opposition filed within time limit [2004/42]
Request for further processing for:23.12.2002Request for further processing filed
11.01.2003Full payment received (date of receipt of payment)
Request granted
20.01.2003Decision despatched
Fees paidRenewal fee
04.03.2002Renewal fee patent year 03
21.03.2003Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US5364850  (HANSEN JR DONALD W [US], et al) [A] 1,8,9,12,13* abstract *;
 [A]US5389645  (HANSEN JR DONALD W [US], et al) [A] 1,8,9,12,13 * page 2, column 2 - page 3, column 1 *;
 [A]WO9622276  (NIPPON SHINYAKU CO LTD [JP], et al) [A] 1,8,9,12,13 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.